Older adults with Graves' disease are more likely to maintain normal thyroid function after radioactive iodine treatment than younger adults, even when the dose and early thyroid changes are taken into account.
Evidence from Studies
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
A systematic review would determine whether age consistently predicts euthyroidism across populations, accounting for differences in radioactive iodine dosing, TRAb levels, and thyroid volume.
A systematic review and meta-analysis of prospective cohort studies reporting age and long-term thyroid function outcomes (euthyroidism, hypothyroidism, hyperthyroidism) after radioactive iodine in Graves' disease, including ≥15 studies with >1000 total patients, standardized outcome definitions, and adjusted analyses for TRAb and dose.
An RCT could test whether age modifies the effect of radioactive iodine dosing on achieving euthyroidism, isolating age as a biological modifier.
A double-blind, randomized trial of 400 adults with Graves' disease stratified by age group (40–55 vs. 56–75), randomized to receive either 150 Gy or 200 Gy per gram of thyroid tissue, with primary outcome: euthyroidism (TSH 0.4–4.2 mIU/L) at 12 months, secondary outcomes: time to euthyroidism and recurrence.
A prospective cohort study could determine whether age independently predicts euthyroidism after adjusting for TRAb, dose, and ETH status.
A prospective cohort of 600 adults with Graves' disease, stratified by age (40–55, 56–75), all treated with standardized radioactive iodine dosing (150–200 Gy per gram), followed for 24 months with monthly thyroid function tests; primary outcome: euthyroidism (TSH 0.4–4.2 mIU/L) at 12 months, adjusted for TRAb, thyroid volume, and ETH status.
A case-control study could compare age distribution between patients who achieved euthyroidism versus those who became hypothyroid or remained hyperthyroid.
A case-control study of 200 patients with Graves' disease: 100 cases with euthyroidism (TSH 0.4–4.2 mIU/L at 24 months) and 100 controls with permanent hypothyroidism or persistent hyperthyroidism, matched for TRAb, thyroid volume, and radioactive iodine dose, with retrospective age data.
A cross-sectional study could describe the age distribution among patients with established euthyroidism after radioactive iodine, but cannot determine whether age caused the outcome.
A cross-sectional survey of 300 adults with euthyroidism (>2 years post-radioactive iodine) for Graves' disease, assessing their age at treatment and baseline characteristics via medical records.